Granahan Investment Management’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-110,824
| Closed | -$2.95M | – | 164 |
|
|
2024
Q4 | $2.95M | Sell |
110,824
-314,396
| -74% | -$8.38M | 0.12% | 137 |
|
|
2024
Q3 | $12.1M | Sell |
425,220
-633,721
| -60% | -$18.1M | 0.48% | 67 |
|
|
2024
Q2 | $23.1M | Sell |
1,058,941
-568,283
| -35% | -$12.4M | 0.92% | 29 |
|
|
2024
Q1 | $36M | Sell |
1,627,224
-539,247
| -25% | -$11.9M | 1.27% | 17 |
|
|
2023
Q4 | $46.8M | Sell |
2,166,471
-321,202
| -13% | -$6.93M | 1.54% | 15 |
|
|
2023
Q3 | $42M | Sell |
2,487,673
-41,758
| -2% | -$705K | 1.5% | 17 |
|
|
2023
Q2 | $34.7M | Buy |
2,529,431
+1,329,382
| +111% | +$18.2M | 1.07% | 24 |
|
|
2023
Q1 | $27.3M | Buy |
1,200,049
+155,721
| +15% | +$3.54M | 0.83% | 34 |
|
|
2022
Q4 | $24.6M | Buy |
1,044,328
+282,111
| +37% | +$6.64M | 0.75% | 34 |
|
|
2022
Q3 | $19.9M | Sell |
762,217
-144,547
| -16% | -$3.77M | 0.65% | 43 |
|
|
2022
Q2 | $19.9M | Buy |
906,764
+113,049
| +14% | +$2.48M | 0.68% | 37 |
|
|
2022
Q1 | $35.6M | Buy |
793,715
+56,341
| +8% | +$2.53M | 0.88% | 33 |
|
|
2021
Q4 | $31.6M | Buy |
737,374
+286,394
| +64% | +$12.3M | 0.65% | 38 |
|
|
2021
Q3 | $30M | Buy |
450,980
+6,351
| +1% | +$422K | 0.57% | 40 |
|
|
2021
Q2 | $32.6M | Buy |
444,629
+160,408
| +56% | +$11.8M | 0.61% | 42 |
|
|
2021
Q1 | $19.5M | Buy |
284,221
+57,233
| +25% | +$3.92M | 0.41% | 57 |
|
|
2020
Q4 | $15.2M | Sell |
226,988
-140,897
| -38% | -$9.46M | 0.34% | 69 |
|
|
2020
Q3 | $18.9M | Buy |
367,885
+92,255
| +33% | +$4.75M | 0.64% | 48 |
|
|
2020
Q2 | $10.4M | Buy |
275,630
+234,900
| +577% | +$8.85M | 0.38% | 72 |
|
|
2020
Q1 | $1.21M | Sell |
40,730
-12,133
| -23% | -$362K | 0.07% | 160 |
|
|
2019
Q4 | $1.82M | Buy |
+52,863
| New | +$1.82M | 0.08% | 142 |
|